• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 69 of 100
CNBC Events
Health
Allergan’s CEO Just Pledged a ‘Social Contract’ With Patients on Drug Prices
By Sy MukherjeeSeptember 6, 2016
One analyst thinks Mylan's EpiPen price hike ties back to its executive incentive plans.
Health
Mylan’s EpiPen Problems Just Got a Whole Lot Worse
By Sy Mukherjee and ReutersSeptember 6, 2016
PillPack
Finance
PillPack Is Raising More Money to Take On Pharmacies
By Dan PrimackSeptember 6, 2016
Biogen Drug Shows Early Promise against Alzheimer’s Disease
Tech
Biogen Drug Shows Early Promise against Alzheimer’s Disease
By David Z. MorrisSeptember 3, 2016
Democratic Presidential candidate and former U.S. Secretary of State Hillary Clinton Campaigns In Iowa
Leadership
Hillary Clinton Says You Won’t See Price Hikes On Life-Saving Drugs if She’s Elected
By ReutersSeptember 2, 2016
FRANCE-POLITICS-INDUSTRY
Health
U.S. Headwinds Force Change of CEO at Novo Nordisk
By ReutersSeptember 1, 2016
The Davos World Economic Forum 2015
Health
Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share
By Sy MukherjeeAugust 31, 2016
Abbott To Sell Generic Drug Unit To Mylan For $5.3 Billion
Finance
Alere Is Suing to Force Abbott to Complete Their $5.8 Billion Merger
By ReutersAugust 26, 2016
US-HEALTH-DRUGS-CONSUMER-POLITICS-MYLAN
Finance
What Mylan’s EpiPen Cost Scandal Says About the Drug Price Problem
By Jen WiecznerAugust 25, 2016
Fortune Most Powerful Women Summit 2015
Health
Mylan Halves EpiPen Price After Being Savaged by Clinton
By Reuters and Fortune EditorsAugust 25, 2016
Mylan NV Chief Executive Officer Heather Bresch Interview
Finance
Mylan CEO Blamed Obamacare for EpiPen Sticker Shock
By Jen WiecznerAugust 24, 2016
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Finance
Here’s Why Mylan Has Something to Be Happy About Today
By Lucinda ShenAugust 24, 2016
Democratic Presidential Nominee Hillary Clinton Delivers Speech On The Economy
Health
Pharma Bro Martin Shkreli Takes On Hillary Clinton Over Mylan’s EpiPen
By Sy MukherjeeAugust 24, 2016
A sign is seen at an AstraZeneca site in Macclesfield
Health
AstraZeneca Is Selling Its Antibiotics Business to Pfizer
By Reuters and Michelle TohAugust 24, 2016
Senator Amy Klobuchar, D-MN, listens to
Health
Lawmakers Are Demanding Investigations Into Mylan’s Huge EpiPen Price Hike
By Sy MukherjeeAugust 23, 2016
1...
  • 67
  • 68
  • 69
  • 70
  • 71
...100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.